GE HealthCare (GEHC) and DeepHealth, a subsidiary of RadNet, are expanding their existing strategic collaboration to advance AI in medical imaging and remote capabilities for ultrasound.
The agreement builds on the two companies' collaboration since 2024, when DeepHealth integrated its AI-powered breast cancer screening workflow software with GEHC’s Senographe Pristina mammography system.
The two firms will extend access to breast cancer technologies worldwide, incorporate GEHC's ultrasound imaging into DeepHealth’s AI-powered Thyroid Suite, and integrate DeepHealth’s TechLive remote scanning software with GEHC’s ultrasound portfolio, they noted.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
